We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Tissue Regenix Group Plc | LSE:TRX | London | Ordinary Share | GB00BNTXR104 | ORD 0.1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| -0.50 | -1.47% | 33.50 | 32.00 | 35.00 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 34.00 | 33.00 | 34.00 | 24,283 | 15:52:56 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 29.49M | -302k | -0.0043 | -77.91 | 24M |
| Date | Time | Source | Headline |
|---|---|---|---|
| 09/6/2025 | 11:22 | ALNC |  Tissue Regenix receives EU certification for OrthoPure XT technology |
| 09/6/2025 | 07:00 | UK RNS | Tissue Regenix Group PLC CE & UKCA certification for OrthoPure® XT |
| 24/4/2025 | 09:38 | UK RNS | Cavendish Securities PLC Form 8.5 (EPT/NON-RI)- Tissue Regenix Group Plc |
| 15/4/2025 | 09:23 | UK RNS | Cavendish Securities PLC Form 8.5 (EPT/NON-RI) |
| 10/4/2025 | 09:09 | UK RNS | Cavendish Securities PLC Form 8.5 (EPT/NON-RI) |
| 09/4/2025 | 10:45 | UK RNS | Cavendish Securities PLC Form 8.5 (EPT/NON-RI) |
| 08/4/2025 | 07:00 | UK RNS | Tissue Regenix Group PLC Conclusion of Strategic Review & Offer Period |
| 07/4/2025 | 08:46 | UK RNS | Cavendish Securities PLC Form 8.5 (EPT/NON-RI) |
| 01/4/2025 | 09:12 | UK RNS | Cavendish Securities PLC Form 8.5 (EPT/NON-RI) |
| 31/3/2025 | 09:21 | UK RNS | Cavendish Securities PLC Form 8.5 (EPT/NON-RI) |
1 Year Tissue Regenix Chart |
Intraday Tissue Regenix Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
